Jim Cramer on Smith & Nephew: "This Group, I Do Not Like"

Smith & Nephew plc (NYSE:SNN) is one of the stocks Jim Cramer recently looked at. When a caller inquired about the stock, Cramer was quick to say:

They have to, they have to be sold, okay? I just, this group, I do not like. Okay, I just don’t like them because it’s commoditized, alright? I remember I asked my wife… she got a new knee, I said, well, who’d you use? Which one? She goes, it doesn’t matter. And that’s the answer.

Smith & Nephew plc (NYSE:SNN) manufactures medical technologies, including joint implants, sports medicine repair tools, and visualization systems for minimally invasive surgeries.

While we acknowledge the potential of SNN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.